EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+10.28%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$5.07B
AUM Growth
+$5.07B
(-0.23%)
Cap. Flow
-$254M
Cap. Flow
% of AUM
-5.01%
Top 10 Holdings %
Top 10 Hldgs %
24.83%
Holding
160
New
22
Increased
53
Reduced
26
Closed
17
Top Buys
| 1 |
Flywire
FLYW
|
$54.4M |
| 2 |
Evolent Health
EVH
|
$47.3M |
| 3 |
dLocal
DLO
|
$32M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$31.2M |
| 5 |
DoubleVerify
DV
|
$30.1M |
Top Sells
| 1 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$180M |
| 2 |
Cintas
CTAS
|
$108M |
| 3 |
Biohaven
BHVN
|
$74.9M |
| 4 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
$68M |
| 5 |
MongoDB
MDB
|
$57.4M |
Sector Composition
| 1 | Healthcare | 43.02% |
| 2 | Technology | 24.93% |
| 3 | Industrials | 12.87% |
| 4 | Consumer Discretionary | 5.44% |
| 5 | Utilities | 4.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
nVent Electric
NVT
$14.5B
| $32.5M | 0.64% | 845,056 -28,244 | -3% | -$1.09M |
|
52
Brookfield Renewable
BEP
$7.2B
| $31.3M | 0.62% | 1,236,000 | – | – |
|
|
SGEN
53
DELISTED
Seagen Inc. Common Stock
SGEN
| $31.2M | 0.61% | +242,545 | New | +$31.2M |
|
54
Verisk Analytics
VRSK
$37.5B
| $30.4M | 0.6% | 172,193 +14,393 | +9% | +$2.54M |
|
55
Cogent Biosciences
COGT
$1.69B
| $29.9M | 0.59% | 2,589,778 -271,114 | -9% | -$3.13M |
|
56
Royalty Pharma
RPRX
$15.6B
| $29.6M | 0.58% | +748,423 | New | +$29.6M |
|
|
VECT
57
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| $29.3M | 0.58% | 3,405,644 +1,066,600 | +46% | +$9.18M |
|
58
Nasdaq
NDAQ
$54.4B
| $28.9M | 0.57% | 471,583 +34,358 | +8% | +$2.11M |
|
59
BILL Holdings
BILL
$4.72B
| $28.9M | 0.57% | 265,310 +252,810 | +2,022% | +$27.5M |
|
60
CDW
CDW
$21.6B
| $27.7M | 0.55% | 155,167 +12,467 | +9% | +$2.23M |
|
61
Inspire Medical Systems
INSP
$2.77B
| $27.3M | 0.54% | 108,220 +24,170 | +29% | +$6.09M |
|
62
Prothena Corp
PRTA
$441M
| $26.4M | 0.52% | 438,732 +208,732 | +91% | +$12.6M |
|
63
Steris
STE
$24.1B
| $25.8M | 0.51% | 139,445 +93 | +0.1% | +$17.2K |
|
64
Cytokinetics
CYTK
$4.23B
| $25.5M | 0.5% | +556,000 | New | +$25.5M |
|
65
Xenon Pharmaceuticals
XENE
$2.98B
| $25.3M | 0.5% | 641,200 | – | – |
|
|
BCYC
66
Bicycle Therapeutics
BCYC
$511M
| $25.3M | 0.5% | 853,800 | – | – |
|
67
Williams Companies
WMB
$70.7B
| $25.1M | 0.5% | 762,939 +10,039 | +1% | +$330K |
|
68
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.51B
| $23.8M | 0.47% | 822,664 | – | – |
|
69
BioMarin Pharmaceuticals
BMRN
$11.2B
| $23.8M | 0.47% | +230,000 | New | +$23.8M |
|
70
Aura Biosciences
AURA
$389M
| $23.6M | 0.47% | +2,251,368 | New | +$23.6M |
|
71
Privia Health
PRVA
$2.83B
| $22.7M | 0.45% | 1,000,000 +584,015 | +140% | +$13.3M |
|
72
iRhythm Technologies
IRTC
$5.46B
| $22.4M | 0.44% | 239,135 +90,305 | +61% | +$8.46M |
|
|
NARI
73
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $22.2M | 0.44% | 349,711 +83,681 | +31% | +$5.32M |
|
74
Brookfield Renewable
BEPC
$6.05B
| $21.3M | 0.42% | 775,019 | – | – |
|
75
Synopsys
SNPS
$112B
| $20.6M | 0.41% | 64,371 +12,205 | +23% | +$3.9M |
|